Quad-C Announces Sale of Boulder Scientific Company

Résumé détaillé

CHARLOTTESVILLE, Va., Nov. 11, 2026 /PRNewswire/ -- Quad-C Management ("Quad-C"), a leading middle market private equity firm, announced that it has closed the sale of Boulder…

CHARLOTTESVILLE, Va., Nov. 11, 2026 /PRNewswire/ -- Quad-C Management ("Quad-C"), a leading middle market private equity firm, announced that it has closed the sale of Boulder Scientific Company ("Boulder Scientific" or the "Company") to Iron Path Capital. Terms of the transaction were not disclosed.

Headquartered in Longmont, Colorado, Boulder Scientific is a leading manufacturer of high-performance organometallic compounds and a provider of complex synthetic chemistry capabilities. For more than six decades, the Company has supplied specialty chemicals to customers in the plastics, microelectronics, defense and aerospace industries in the United States and around the world.

Quad-C partnered with Boulder Scientific's founding family and management team to support the Company's transition from family ownership and to accelerate its growth. During Quad-C's ownership, Boulder Scientific fortified its leadership team, made significant capital investments in its production facilities to expand capacity and extend capabilities, and expanded its technical and commercial capabilities to serve a broader set of customers and end markets including semiconductor materials and aerospace & defense.

Rich Preziotti, CEO of Boulder Scientific, commented, "Quad-C has been an exceptional partner, providing the resources and strategic support that positioned us to grow and expand into new markets. Boulder Scientific's chemistry is truly differentiated, and in partnership with the Quad-C team, we have strengthened the company's global market position while maintaining our technical excellence and commitment to quality and safety."

"It has been a privilege to partner with Rich, Scott Birmingham, and the entire Boulder Scientific team," added Tom Hickey, Quad-C Senior Partner. "We believe that Boulder Scientific's unique technical capabilities in organometallic and complex synthetic chemistry position the company to drive growth and we wish them continued success in their next phase."

"Boulde…

Début de l'article, extrait de PR Newswire. Pour lire la suite, ouvrez l'article chez le média.